MedComm – Oncology Journal Specifications
Indexed in the following public directories
- DOAJ
Overview | |
Publisher | Wiley |
Language | English |
Article Processing Charges | USD 2800 |
Publication Time | 15 |
Editorial Review Process | Anonymous peer review |
General Details | |
Language | English |
Society/Institute/Sponsor | Sichuan International Medical Exchange & Promotion Association (SCIMEA) |
Website URL | Visit website |
Publication Details | |
Editorial Review Detail | |
Information for authors | |
Author instructions | Visit website |
Copyright Details | Visit website |
Deposit Policy | Sherpa/Romeo |
License type | CC BY |
OA statement | Visit website |
View less
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers in MedComm – Oncology
Title not available
- 1 Dec 2024
- MedComm – Oncology
Immunotherapy for gastric cancer: Advances and challenges
- 4 Nov 2024
- MedComm – Oncology
Nanoparticle‐encapsuled celastrol‐Fe(III): “Single‐edged sword” for tumor therapy featuring microenvironment‐dependent toxicity
- 28 Oct 2024
- MedComm – Oncology
Extracellular vesicles in cancer drug resistance: Mechanistic insights and therapeutic implications
- 24 Oct 2024
- MedComm – Oncology
MiRNA interplay: Mechanisms and therapeutic interventions in cancer
- 15 Oct 2024
- MedComm – Oncology
KMT2C/D deficiency promotes breast cancer metastasis by regulating KDM6A‐mediated epigenetic remodeling
- 14 Oct 2024
- MedComm – Oncology
Title not available
- 1 Dec 2024
- MedComm – Oncology
Immunotherapy for gastric cancer: Advances and challenges
- 4 Nov 2024
- MedComm – Oncology
Nanoparticle‐encapsuled celastrol‐Fe(III): “Single‐edged sword” for tumor therapy featuring microenvironment‐dependent toxicity
- 28 Oct 2024
- MedComm – Oncology
Extracellular vesicles in cancer drug resistance: Mechanistic insights and therapeutic implications
- 24 Oct 2024
- MedComm – Oncology
MiRNA interplay: Mechanisms and therapeutic interventions in cancer
- 15 Oct 2024
- MedComm – Oncology
KMT2C/D deficiency promotes breast cancer metastasis by regulating KDM6A‐mediated epigenetic remodeling
- 14 Oct 2024
- MedComm – Oncology
FAQs on MedComm – Oncology
How many articles did MedComm – Oncology publish last year?
In 2023, MedComm – Oncology publsihed 46 articles.
Who is the publisher of MedComm – Oncology?
Wiley is the publisher of MedComm – Oncology.